Context Partners Fund’s Japer Therapeutics Warrants JSPRW Stock Holding History

Context Partners Fund’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$30K	Buy	+25,000	New	+$25.3K	0.01%	154

Other funds holding JSPRW

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Context Partners Fund's JSPRW Position: Q3 2020 in Review

Context Partners Fund opened a new position in Japer Therapeutics Warrants (JSPRW) in Q3 2020: 25,000 shares worth $30K. The stake represents 0.01% of the portfolio and ranks #154 among its holdings.

35 funds tracked by Wall St. Rank hold JSPRW as of Q3 2020.

Context Partners Fund held 25,000 shares of Japer Therapeutics Warrants worth $30K as of Q3 2020.
Japer Therapeutics Warrants was a new Context Partners Fund position in Q3 2020.
Japer Therapeutics Warrants made up 0.01% of Context Partners Fund's portfolio in Q3 2020, its #154 holding.
35 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2020.

Based on Context Partners Fund's 13F filing for Q3 2020, filed 16 Nov 2020.